Search This Blog

Thursday, October 6, 2022

Statera to deal with listing requirements

 

  • Statera Biopharma (STAB) stock is gaining as it meets with The Nasdaq Stock Market.
  • This has to do with it not meeting listing requirements.
  • The company intends to request an extension to address the exchange's complaints.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.